SYDNEY, AU, Feb 3, 2023 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific focused biotech specialist CRO and recipient of the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence award, said the number of cell & gene therapy trials in the region was growing 50% faster than ROW. The majority of... » read more
HONG KONG, Jan 12, 2023 – (ACN Newswire via SEAPRWire.com) – The leading provider of fuel cell systems in China – Beijing SinoHytec Co., Ltd. (“SinoHytec” or the “Company”, Stock Code: 2402), has successfully listed and commenced dealings on the Main Board of the Stock Exchange of Hong Kong Limited (“Hong Kong Stock Exchange” or... » read more
HONG KONG, Dec 29, 2022 – (ACN Newswire via SEAPRWire.com) – The leading provider of fuel cell systems in China – Beijing SinoHytec Co., Ltd. (“SinoHytec” or the “Company”, Stock Code: 2402), today announced the proposed listing of its shares on the Main Board of the Stock Exchange of Hong Kong Limited ( the “Hong... » read more
PETALING JAYA, Malaysia, Nov 23, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today reported a revenue of RM3.81 million for the first quarter ended 30 September 2022 (1Q 2023) versus a revenue of RM9.32 million in 1Q 2022, as the Group refocuses on immunotherapy... » read more
SYDNEY, AU, Sep 15, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Cell & Gene Therapy Clinical Trials award at the 6th Cell & Gene Therapy World Asia 2022 conference. Novotech has extensive experience in cell & gene therapy clinical trials across Asia Pacific.... » read more
PETALING JAYA, Malaysia, Jul 13, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that it has entered into a strategic partnership with United Doctors Hospital (UDH) for collaboration in genomics and cell therapies. Azri Azerai, Executive Director of Malaysian Genomics... » read more
HONG KONG, Mar 31, 2022 – (ACN Newswire via SEAPRWire.com) – Weichai Power Company Limited (“Weichai Power” or the “Company”, SEHK stock code: 2338.HK; Shenzhen Stock Exchange stock code: 000338.SZ) announced its annual results for the year ended 31 December 2021 (the “year”) on 30th March, prepared in accordance with PRC accounting standards. Steady growth... » read more
Torrance, Calif., Mar 15, 2022 – (JCN Newswire via SEAPRWire.com) – Honda today announced plans to install a stationary fuel cell power station on its corporate campus in Torrance, Calif. by early 2023. The station will serve as a proof of concept for the future commercialization of a power generation unit for use as a... » read more
TOKYO, Mar 7, 2022 – (JCN Newswire via SEAPRWire.com) – Fujitsu and the Tokyo Medical and Dental University (TMDU) today announced a new technology that uses AI to discover new causal mechanisms of drug resistance in cancer treatments from clinical data. Leveraging the world’s fastest supercomputer “Fugaku,”(1) the new technology enables high-speed calculation of 20,000... » read more
HONG KONG, Jan 13, 2022 – (ACN Newswire via SEAPRWire.com) – At 9:00 am on January 8, 2022, Weichai Power (Stock codes: 2338.HK; 000338.SZ) released the world’s first diesel engine with a base engine thermal efficiency of 51.09% and major achievements in hydrogen technology achievements. Tan Xuguang, CPC Secretary and Chairman of Shandong Heavy Industry... » read more
TOKYO and KENILWORTH, N.J., Nov 29, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Canada) today announced that the European Commission has approved the combination of LENVIMA (KISPLYX in the European Union [EU] for the treatment of advanced renal... » read more
TOKYO and KENILWORTH, N.J., Oct 18, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Canada) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted positive opinions recommending approval of... » read more
Shanghai, China / TickerInsider / August 27, 2021 / – In the evening of August 26, Shanghai Economic and Information Commission officially announced that the Shanghai government plans to build close to 100 hydrogen fuel refueling stations, forming an output scale of nearly 100 billion yuan and promoting close to 10,000 fuel cell vehicles. Meijin Energy... » read more
Texas, Dec 11, 2020 – (JCN Newswire) – Toyota’s next generation fuel cell electric technology is now powering a new set of Class 8 heavy-duty trucks. Using the same fuel cell system as the all-new 2021 Mirai sedan that goes on sale this month, the engineers at Toyota Motor North America Research and Development have... » read more
TOKYO, Dec 8, 2020 – (JCN Newswire) – Toyota Motor Corporation and Hino Motors, Ltd., together with Seven-Eleven Japan Co., Ltd., FamilyMart Co., Ltd., and Lawson, Inc., have agreed to jointly consider introducing light-duty fuel cell electric trucks (light-duty FCETs), and to establish an environment for its widespread use in the future, targeting the realization... » read more
Vancouver, BC, Nov 11, 2020 – (ACN Newswire) – BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) (“BioVaxys”) is pleased to announce that results from its preclinical animal study (also known as the “murine model study”) of BVX-0320, its Covid-19 vaccine candidate, show that the vaccine elicits a positive immune response against the SARS-CoV-2 s-spike protein.... » read more